Solventum's (NYSE:SOLV) Q4 CY2025 Sales Top Estimates

robot
Abstract generation in progress

Solventum (NYSE:SOLV) exceeded revenue estimates in Q4 CY2025, reporting $2.00 billion, though sales decreased by 3.7% year-over-year. However, its GAAP EPS of $0.36 significantly missed analyst expectations. Despite beating revenue, the company’s long-term revenue growth has been flat, and analysts expect further revenue decline and a substantial shrink in EPS for the upcoming year.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin